Table 1

Focal regions of CNA regions in gastric cancer

CNAChrStartEndLength (kb)CytobandQ valueGenes in peak
Amplification
 110123 336 181123 337 7131.510q26.133.9561E-99FGFR2
 28128 628 340128 670 25141.98q24.217.984E-27[MYC]
 31934 982 65235 002 39719.719q123.1439E-23CCNE1
 41225 213 92025 336 398122.512p12.11.5713E-14KRAS, CASC1, LYRM5
 51817 947 47418 040 78393.318q11.21.0616E-13GATA6
 6521 377 83821 406 30828.55p14.39.501E-12[CDH12]
 7791 921 07992 111 471190.47q21.22.0612E-10CDK6, PEX1, GATAD1, DKFZP564O0523, FAM133B
 8811 346 68811 659 701313.08p23.19.0544E-10BLK, GATA4, C8orf13
 9755 237 44755 373 693136.27p11.22.4109E-09EGFR
 101735 102 11835 136 33534.217q123.8268E-09ERBB2
 111372 528 93772 770 614241.713q22.11.4729E-07KLF5
 121169 161 01969 306 967145.911q13.29.1737E-07CCND1, FGF4, FGF19, ORAOV1
 137115 987 034116 178 774191.77q31.20.00012527CAV1, MET
Deletion
 1360 447 45160 472 96425.53p14.23.4002E-41FHIT
 284 182 6354 182 9160.38p23.21.0797E-18CSMD1
 3921 953 41921 995 19241.89p21.31.0299E-17CDKN2A, CDKN2B
 462 019 5382 068 88049.36p25.31.7756E-14GMDS
 51677 269 20977 293 23224.016q23.15.4871E-12WWOX
 66162 551 244162 610 87459.66q262.1056E-11PARK2
 71347 806 67747 809 3752.713q14.23.3682E-11RB1
 8558 436 44158 569 237132.85q11.21.6661E-10PDE4D
 999 524 0639 675 303151.29p231.2287E-09PTPRD
  • Focal recurrent CNA (amplifications and deletions) identified by genomic identification of significant targets in cancer (GISTIC). Genes previously reported as oncogenes or tumour suppressor genes are highlighted in bold. Start and end indicates the boundary of the region identified. Length indicates size of each region identified. Q value represents the significance of the recurrent CNA region across all the gastric tumours. Genes in peak, genes covered by the corresponding region, a square bracket indicates that the gene lies immediately adjacent to the peak.